COAG Hemab Therapeutics Holdings, Inc.

NASDAQ

$31.06

Hemab Therapeutics Holdings, Inc. (COAG) Earnings News

Earnings press releases, previews and reviews for Hemab Therapeutics Holdings, Inc. (COAG), newest first.

Tuesday August 11, 2026 7:00 AM ET

Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Thursday May 21, 2026 7:00 AM ET

Hemab Therapeutics Reports First Quarter 2026 Financial Results